144 related articles for article (PubMed ID: 8920997)
1. Identification of a novel opioid peptide (Tyr-Val-Pro-Phe-Pro) derived from human alpha S1 casein (alpha S1-casomorphin, and alpha S1-casomorphin amide).
Kampa M; Loukas S; Hatzoglou A; Martin P; Martin PM; Castanas E
Biochem J; 1996 Nov; 319 ( Pt 3)(Pt 3):903-8. PubMed ID: 8920997
[TBL] [Abstract][Full Text] [Related]
2. Antiproliferative and receptor binding properties of alpha- and beta-casomorphins in the T47D human breast cancer cell line.
Hatzoglou A; Bakogeorgou E; Hatzoglou C; Martin PM; Castanas E
Eur J Pharmacol; 1996 Aug; 310(2-3):217-23. PubMed ID: 8884220
[TBL] [Abstract][Full Text] [Related]
3. Opioid alkaloids and casomorphin peptides decrease the proliferation of prostatic cancer cell lines (LNCaP, PC3 and DU145) through a partial interaction with opioid receptors.
Kampa M; Bakogeorgou E; Hatzoglou A; Damianaki A; Martin PM; Castanas E
Eur J Pharmacol; 1997 Sep; 335(2-3):255-65. PubMed ID: 9369381
[TBL] [Abstract][Full Text] [Related]
4. The antiproliferative effect of opioid receptor agonists on the T47D human breast cancer cell line, is partially mediated through opioid receptors.
Hatzoglou A; Bakogeorgou E; Castanas E
Eur J Pharmacol; 1996 Jan; 296(2):199-207. PubMed ID: 8838457
[TBL] [Abstract][Full Text] [Related]
5. Beta-casomorphin-5 stimulates neurite outgrowth in a mouse neuroblastoma cell line (Neuro-2a).
Sakaguchi M; Murayama K; Yabe K; Satoh M; Takeuchi M; Matsumura E
Neurosci Lett; 1998 Jul; 251(2):97-100. PubMed ID: 9718983
[TBL] [Abstract][Full Text] [Related]
6. Novel opioid peptides derived from casein (beta-casomorphins). II. Structure of active components from bovine casein peptone.
Henschen A; Lottspeich F; Brantl V; Teschemacher H
Hoppe Seylers Z Physiol Chem; 1979 Sep; 360(9):1217-24. PubMed ID: 511111
[TBL] [Abstract][Full Text] [Related]
7. Identification of casoxin C, an ileum-contracting peptide derived from bovine kappa-casein, as an agonist for C3a receptors.
Takahashi M; Moriguchi S; Suganuma H; Shiota A; Tani F; Usui H; Kurahashi K; Sasaki R; Yoshikawa M
Peptides; 1997; 18(3):329-36. PubMed ID: 9145417
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships of alphaS1-casomorphin using AM1 calculations and molecular dynamics simulations.
Wu YC; Lin JS; Hwang CC
J Phys Chem B; 2007 Jun; 111(25):7377-83. PubMed ID: 17530883
[TBL] [Abstract][Full Text] [Related]
9. Enzymatic release of neocasomorphin and beta-casomorphin from bovine beta-casein.
Jinsmaa Y; Yoshikawa M
Peptides; 1999; 20(8):957-62. PubMed ID: 10503774
[TBL] [Abstract][Full Text] [Related]
10. Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum.
Schoffelmeer AN; Hogenboom F; Mulder AH
Br J Pharmacol; 1997 Oct; 122(3):520-4. PubMed ID: 9351509
[TBL] [Abstract][Full Text] [Related]
11. Tyr-c[D-Orn-Tyr(Bzl)-Pro-Gly]: a novel antiproliferative acting somatostatin receptor agonist with mu-opioid receptor-sensitizing properties.
Stirnweiss J; Hartrodt B; Greksch G; Stürzebecher U; Böhmer FD; Neubert K; Liebmann C
Br J Pharmacol; 2003 Sep; 140(1):13-22. PubMed ID: 12967930
[TBL] [Abstract][Full Text] [Related]
12. Receptorphin: a conserved peptide derived from the sequence of the opioid receptor, with opioid displacement activity and potent antiproliferative actions in tumor cells.
Kampa M; Loukas S; Tsapis A; Castanas E
BMC Pharmacol; 2001; 1():9. PubMed ID: 11737867
[TBL] [Abstract][Full Text] [Related]
13. Milk bioactive peptides and beta-casomorphins induce mucus release in rat jejunum.
Trompette A; Claustre J; Caillon F; Jourdan G; Chayvialle JA; Plaisancié P
J Nutr; 2003 Nov; 133(11):3499-503. PubMed ID: 14608064
[TBL] [Abstract][Full Text] [Related]
14. Effect of casein and beta-casomorphins on gastrointestinal motility in rats.
Daniel H; Vohwinkel M; Rehner G
J Nutr; 1990 Mar; 120(3):252-7. PubMed ID: 2319342
[TBL] [Abstract][Full Text] [Related]
15. Opioids are non-competitive inhibitors of nitric oxide synthase in T47D human breast cancer cells.
Kampa M; Hatzoglou A; Notas G; Niniraki M; Kouroumalis E; Castanas E
Cell Death Differ; 2001 Sep; 8(9):943-52. PubMed ID: 11526449
[TBL] [Abstract][Full Text] [Related]
16. Characterization of specific opioid binding sites in neural membranes from the myenteric plexus of porcine small intestine.
Townsend D; Portoghese PS; Brown DR
J Pharmacol Exp Ther; 2004 Jan; 308(1):385-93. PubMed ID: 14569065
[TBL] [Abstract][Full Text] [Related]
17. Differential coupling of mu-, delta-, and kappa-opioid receptors to G alpha16-mediated stimulation of phospholipase C.
Lee JW; Joshi S; Chan JS; Wong YH
J Neurochem; 1998 May; 70(5):2203-11. PubMed ID: 9572309
[TBL] [Abstract][Full Text] [Related]
18. Opioid antagonist properties of the highly delta-receptor-selective BOC-Tyr-Pro-Gly-Phe-Leu-Thr (OtBu) peptide and of its Phe1 and Mel1 analogues.
Rónai AZ; Magyar A; Orosz G; Borsodi A; Benyhe S; Tóth G; Makó E; Kátay E; Babka E; Medzihradszky K
Arch Int Pharmacodyn Ther; 1995; 330(3):361-9. PubMed ID: 8836454
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of opioid and somatostatin binding sites in the opossum kidney (OK) cell line and their effect on growth.
Hatzoglou A; Bakogeorgou E; Papakonstanti E; Stournaras C; Emmanouel DS; Castanas E
J Cell Biochem; 1996 Dec; 63(4):410-21. PubMed ID: 8978457
[TBL] [Abstract][Full Text] [Related]
20. Release of β-casomorphin-7/5 during simulated gastrointestinal digestion of milk β-casein variants from Indian crossbred cattle (Karan Fries).
Ul Haq MR; Kapila R; Kapila S
Food Chem; 2015 Feb; 168():70-9. PubMed ID: 25172685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
